Global CRO Announces Extension Agreement for OmniComm’s TrialOne
A global CRO has expanded its existing partnership with OmniComm Systems, Inc., a global provider of clinical data management technology. Under this partnership, this CRO has announced a $7.8 million extension agreement for OmniComm’s TrialOne and will utilize OmniComm’s system to ensure regulatory compliance and bring greater operational efficiency, speed, and quality to the clinical research process within its clinics.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Operational Strategies That Strengthened the NIMBLE Trial Design
September 16th 2025